Menu

Reimagining the Board of Director Construct in Life Sciences Companies

This interactive session focused on the discussion of current trends in the construct of Life Science Boards: Achieving Functional Diversity. The panel examined current Board structure and opportunities to expand and attract value added expertise in key functional areas.

This a great opportunity to hear first-hand from some key leaders in the Biopharmaceutical industry that have been actively engaged on several Boards, and have led both public and private companies.

Panelists: David Kabakoff, Ph.D., Executive Partner at Sofinnova Investments, Bill Newell, Chief Executive Officer of Sutro Biopharma, and Rebecca Sunshine, Executive Vice President of Human Resources at Coherus Biosciences.